agilon health (NYSE:AGL) Stock Price Down 7.9% – Time to Sell?

agilon health, inc. (NYSE:AGL)’s share price fell 7.9% during mid-day trading on Thursday . The company traded as low as $3.25 and last traded at $3.23. 2,021,142 shares changed hands during mid-day trading, a decline of 60% from the average session volume of 5,055,943 shares. The stock had previously closed at $3.50.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the stock. Macquarie began coverage on shares of agilon health in a research report on Monday, December 16th. They issued a “neutral” rating and a $3.00 price objective on the stock. Stifel Nicolaus decreased their price target on agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a report on Tuesday, November 12th. Sanford C. Bernstein increased their price objective on agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a report on Wednesday, January 15th. JMP Securities cut agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Finally, Needham & Company LLC began coverage on shares of agilon health in a research note on Friday, January 10th. They issued a “hold” rating on the stock. Two analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, agilon health has a consensus rating of “Hold” and a consensus price target of $4.03.

agilon health Price Performance

The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The company’s 50-day moving average price is $2.52 and its two-hundred day moving average price is $3.36. The company has a market cap of $1.33 billion, a P/E ratio of -3.43 and a beta of 0.66.

agilon health (NYSE:AGL) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The firm had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter in the previous year, the company earned ($0.06) EPS. As a group, sell-side analysts expect that agilon health, inc. will post -0.59 earnings per share for the current year.

Insider Transactions at agilon health

In other agilon health news, Director John William Wulf acquired 45,000 shares of agilon health stock in a transaction dated Thursday, December 5th. The stock was acquired at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the completion of the transaction, the director now owns 206,133 shares in the company, valued at approximately $449,369.94. This represents a 27.93 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Karen Mcloughlin bought 25,000 shares of the stock in a transaction that occurred on Friday, December 13th. The stock was acquired at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the transaction, the director now owns 73,166 shares in the company, valued at $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have acquired 90,000 shares of company stock worth $198,100. 3.20% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the business. Symphony Financial Services Inc. increased its position in shares of agilon health by 44.3% during the 4th quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company’s stock valued at $44,000 after purchasing an additional 7,058 shares during the period. Charles Schwab Investment Management Inc. grew its position in agilon health by 49.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company’s stock worth $8,629,000 after buying an additional 1,498,524 shares during the last quarter. Handelsbanken Fonder AB increased its holdings in shares of agilon health by 47.9% in the fourth quarter. Handelsbanken Fonder AB now owns 75,000 shares of the company’s stock valued at $142,000 after buying an additional 24,300 shares in the last quarter. Ieq Capital LLC bought a new stake in shares of agilon health during the 4th quarter worth $26,000. Finally, Alberta Investment Management Corp acquired a new position in shares of agilon health in the 4th quarter worth $1,564,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.